Skip to main content
. 2017 Aug 4;8(63):107223–107236. doi: 10.18632/oncotarget.19928

Table 3. Risk assessment of the included studies of this systematic review.

First author Were adequate eligibility criteria developed and applied? Was the measurement of both exposure and outcomes adequate? Was confounding adequately controlled for? Was the follow-up complete and adequate in duration? Are reports of the study free of suggestion of selective outcome reporting? Was the study free of other problems that put it at a high risk of bias? Risk of bias
Bidard [33] Yes Yes Yes Yes Yes Yes Low
De Albuquerque [34] Yes Yes Yes Yes Yes Yes Low
Effenberger [35] Yes Yes Yes Yes Yes Yes Low
Hoffmann [36] Yes No Yes Unclear Yes Yes High
Hu [37] Yes Yes Yes Yes Yes Yes Low
Juhl [38] Yes Yes Yes Yes Yes Yes Low
Khoja [39] Yes Yes Yes Yes Yes Yes Low
Klos [40] Yes Yes Yes Yes No Yes High
Kurihara [41] Yes Yes Yes Yes Yes Yes Low
Rehders [42] Yes Yes Yes Yes No Yes High
Roder [43] Yes Yes No No No Yes High
Sergeant [44] Yes Yes Yes Yes Yes Yes Low
Soeth [45] Yes Yes Yes Yes Yes Yes Low
van Heek [46] No Yes No Yes Yes Yes High
Vogel [47] Yes Yes Yes Yes Yes Yes Low
Zhang [48] Yes No Yes No No Yes High